Back
ESC Premium Access

Comparison of contemporary risk scores for predicting mortality and morbidity after mitral valve surgery

Session: Valve repair and assist devices
Topic: Mitral valve surgery
Speaker: Doctor T. Wang (Cleveland, US)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Tom Kai Ming Wang

Cleveland Clinic, Cleveland (United States of America)
0 follower

6 more presentations in this session

Long-term outcome of mitral valve repair versus replacement in a large series of patients with infective endocarditis

Speaker: Associate Professor E. Ruttmann-Ulmer (Innsbruck, AT)

Access
Abstract
Slides
Like
Thumbnail

Performance of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation

Speaker: Mr G. Martin (Manchester, GB)

Access
Abstract
Slides
Like
Thumbnail

Metabolic syndrome affects valve-related adverse events after biological heart valve replacement

Speaker: Doctor E. Angeloni (Rome, IT)

Access
Abstract
Slides
Like
Thumbnail

Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry POL-TAVI.

Speaker: Doctor K. Czerwinska-Jelonkiewicz (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Preservation of arterial pulsatility to prevent acquired von willebrand disease with continuous-flow left ventricular assist device : insights from a pig model

Speaker: Doctor F. Vincent (Lille, FR)

Access
Abstract
Like
Thumbnail

Access the full session

Valve repair and assist devices

Speakers: Doctor T. Wang, Associate Professor E. Ruttmann-Ulmer, Mr G. Martin, Doctor E. Angeloni, Doctor K. Czerwinska-Jelonkiewicz...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources